| abstract |
The present invention relates to an antiviral composition comprising a compound derived from chestnut as an active ingredient, wherein the composition is a virus that causes respiratory diseases, such as Picornaviridae (e.g., HRV1B, CVB3, etc.) or Orthomyxovirus ( Orthomyxoviridae) (for example, PR8, etc.) can be effectively opposed, and can be usefully used as pharmaceutical compositions, health functional foods, skin external preparations and quasi-drugs. |